EPISODE · Apr 23, 2020 · 11 MIN
Fluticasone, Umeclidinium, and Vilanterol Pharmacology
from Real Life Pharmacology - Pharmacology Education for Health Care Professionals
Fluticasone, Umeclidinium, and Vilanterol is a combination medication used in the setting of COPD. I discuss the pharmacology of this agent further in this episode. Fluticasone is the inhaled corticosteroid portion of the drug while umeclidinium is a LAMA and vilanterol is a LABA medication. Drug interactions aren’t incredibly common or strongly clinically significant, but I discuss some of them with Trelegy Ellipta. Having a once-daily dose can be advantageous to help improve patient adherence. Fluticasone, umeclidinium, and vilanterol comes as a once-daily combination. I discuss important drug interactions on the podcast, be sure to check out my latest project which is a 200+ page book on managing drug interactions in primary care. Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!
Embed this episode
NOW PLAYING
Fluticasone, Umeclidinium, and Vilanterol Pharmacology
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.